Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.
Prostate and mammary cancer bone metastases can be osteoblastic or osteolytic, but the mechanisms determining these features are unclear. Bone morphogenetic and Wnt proteins are osteoinductive molecules. Their activity is modulated by antagonists such as noggin and dickkopf-1. Differential expressio...
Main Authors: | Schwaninger, R, Rentsch, C, Wetterwald, A, van der Horst, G, van Bezooijen, R, van der Pluijm, G, Löwik, C, Ackermann, K, Pyerin, W, Hamdy, F, Thalmann, G, Cecchini, MG |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
The osteoblastic response by prostate cancer bone metastases is determined by the lack of expression of noggin and dickkopf-1 (DKK-1)
by: Rentsch, C, et al.
Published: (2007) -
Lack of expression of noggin and Dickkopf-1 (DKK-1) by prostate cancer cells determines the osteoblast response in bone metastasis
by: Rentsch, C, et al.
Published: (2007) -
The role of the BMP signaling antagonist noggin in the development of prostate cancer osteolytic bone metastasis.
by: Chiara Secondini, et al.
Published: (2011-01-01) -
The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
by: Berna C Özdemir, et al.
Published: (2014-01-01) -
Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancer
by: CA Rentsch, et al.
Published: (2009-04-01)